Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 20 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (3)
P 1 (1)
P 2 (8)
P 3 (1)

Trial Status

Unknown8
Recruiting5
Completed5
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT02012699Recruiting

Integrated Cancer Repository for Cancer Research

NCT07532538Not Yet RecruitingPrimary

A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions

NCT05894070Recruiting

The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer

NCT02113878Phase 1Completed

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

NCT05860335Phase 2RecruitingPrimary

Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer

NCT06039631Phase 2Recruiting

Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

NCT05375266Recruiting

Immune Biomarker Study for Head and Neck Cancer

NCT05420597Phase 2Unknown

Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma

NCT04539600Phase 2UnknownPrimary

Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer

NCT03934294Not ApplicableCompleted

Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients

NCT03558035Phase 2UnknownPrimary

New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma

NCT04502641Phase 3UnknownPrimary

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial

NCT01312350Phase 2CompletedPrimary

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

NCT01435252Phase 2Completed

A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab

NCT00473564Not ApplicableCompleted

Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery

NCT01175499Not ApplicableWithdrawn

Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract

NCT01516996Phase 2Unknown

Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer

NCT00174096Unknown

The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

NCT00173381Unknown

The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis

NCT00302562Unknown

The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Showing all 20 trials

Research Network

Activity Timeline